logo

For the Inventor, By the Inventor

Osaka, Japan

Kenju Miura

This inventor holds 7 USPTO granted patents. Top assignees: Suntory Limited, Asubio Pharma Co. Ltd.. Active years: 1989-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenju Miura. Retrieved from https://idiyas.com/inventor/kenju-miura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 85.7

Average Co-Inventor Count = 5.5

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Kyoto, JP (1989 - 1992)
  • Osaka, JP (1998 - 2007)

Company Filing History:

goldMedal6 out of 439 
 
Suntory Limited
 patents
silverMedal1 out of 19 
 
Asubio Pharma Co. Ltd.
 patents

Years Active: 1989-2007

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7282201 - Methods of promoting the growth or differentiation of hematopoietic stem or progenitor cells by non-muscle type cofilin (2007-10-16),
2. 6040335 - Therapeutics for thrombocytopenia (2000-03-21),
3. 5972886 - Megakaryocyte differentiation factor (1999-10-26),
4. 5874253 - DNA encoding megakaryocyte differentiation factor (1999-02-23),
5. 5831030 - Antibodies specific for megakaryocyte differentiation factor (1998-11-03),
6. 5126253 - Cell lines for use in the preparation of hybridoma cells (1992-06-30),
7. 4820641 - Monoclonal antibody capable of specifically distinguishing human (1989-04-11),

Title: Kenju Miura: Innovator in Hematopoietic Stem Cell Research

Introduction

Kenju Miura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of hematopoietic stem cell research, holding a total of 7 patents. His work focuses on developing therapeutics for diseases related to hematopoietic stem cell dysfunction.

Latest Patents

One of Kenju Miura's latest patents is titled "Methods of promoting the growth or differentiation of hematopoietic stem or progenitor cells by non-muscle type cofilin." This invention aims to provide promoters that enhance the growth and differentiation of hematopoietic stem cells and progenitors. These promoters are particularly useful as therapeutics for conditions such as panhematopenia and other diseases associated with hematopoietic hypofunction. The invention utilizes Cofilin as an active ingredient to achieve its therapeutic objectives.

Career Highlights

Throughout his career, Kenju Miura has worked with notable companies, including Suntory Limited and Asubio Pharma Co. Ltd. His innovative approaches have led to advancements in the treatment of hematological disorders.

Collaborations

Kenju Miura has collaborated with esteemed colleagues such as Hiroshi Nakazato and Masafumi Tsujimoto. Their combined expertise has contributed to the success of his research and inventions.

Conclusion

Kenju Miura's work in hematopoietic stem cell research exemplifies the impact of innovation in medical therapeutics. His patents and collaborations highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…